Int J Drug Policy. 2015 Sep 3. pii: S0955-3959(15)00253-4. doi: 10.1016/j.drugpo.2015.08.017. [Epub ahead of print]
By Tommy G. Thompson
"Obesity is a disease that we would be wise to treat early and often, because the other conditions that often afflict obese patients carry painfully high costs, in terms of both dollars and lives. If we are serious about improving the health and wellness of the American people, while also reducing the costs of chronic care, we have to stop waiting for people to get sick before providing care. Whenever possible, we have to take decisive steps earlier in disease progression to stop patients from worsening.
A great first step in the right direction – one that already has bicameral, bipartisan support – would be to allow Medicare Part D to cover obesity medicines."